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ORIGINAL ARTICLE
708 Common and 2010 rare DISC1 locus variants identiﬁed
in 1542 subjects: analysis for association with psychiatric
disorder and cognitive traits
PA Thomson1,2,9, JS Parla3,9, AF McRae4,9, M Kramer3, K Ramakrishnan1, J Yao3, DC Soares1, S McCarthy3, SW Morris1, L Cardone3,
S Cass1, E Ghiban3, W Hennah1,5, KL Evans1,2, D Rebolini3, JK Millar1, SE Harris1,2, JM Starr2, DJ MacIntyre6, Generation Scotland7,
AM McIntosh6, JD Watson3, IJ Deary2, PM Visscher4,8, DH Blackwood6, WR McCombie3 and DJ Porteous1,2
A balanced t(1;11) translocation that transects the Disrupted in schizophrenia 1 (DISC1) gene shows genome-wide signiﬁcant linkage
for schizophrenia and recurrent major depressive disorder (rMDD) in a single large Scottish family, but genome-wide and exome
sequencing-based association studies have not supported a role for DISC1 in psychiatric illness. To explore DISC1 in more detail, we
sequenced 528 kb of the DISC1 locus in 653 cases and 889 controls. We report 2718 validated single-nucleotide polymorphisms
(SNPs) of which 2010 have a minor allele frequency ofo1%. Only 38% of these variants are reported in the 1000 Genomes Project
European subset. This suggests that many DISC1 SNPs remain undiscovered and are essentially private. Rare coding variants
identiﬁed exclusively in patients were found in likely functional protein domains. Signiﬁcant region-wide association was observed
between rs16856199 and rMDD (P¼ 0.026, unadjusted P¼ 6.3 10 5, OR¼ 3.48). This was not replicated in additional recurrent
major depression samples (replication P¼ 0.11). Combined analysis of both the original and replication set supported the original
association (P¼ 0.0058, OR¼ 1.46). Evidence for segregation of this variant with disease in families was limited to those of rMDD
individuals referred from primary care. Burden analysis for coding and non-coding variants gave nominal associations with
diagnosis and measures of mood and cognition. Together, these observations are likely to generalise to other candidate genes
for major mental illness and may thus provide guidelines for the design of future studies.
Molecular Psychiatry advance online publication, 4 June 2013; doi:10.1038/mp.2013.68
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INTRODUCTION
Schizophrenia (SZ), bipolar disorder (BD) and recurrent major
depressive disorder (rMDD) are common forms of serious mental
illness, each with a strong and overlapping genetic component.1–3
Genome-wide linkage, association, cytogenetic, copy number
variant and, more recently, sequencing studies establish that
the genetic architecture of psychiatric illness is complex and that
there is extensive genetic heterogeneity, which is incompletely
deﬁned or understood (reviewed in Sullivan et al.4). We previously
reported a t(1;11) translocation in a single large Scottish family
that showed genome-wide signiﬁcant linkage for SZ, rMDD and
jointly with BD.5 The t(1;11) translocation is balanced and
structurally simple, but the outcome is genetically complex,
disrupting the protein coding gene Disrupted in schizophrenia
1 (DISC1), the antisense non-coding gene Disrupted in
schizophrenia 2 (DISC2) and the non-coding gene DISC1FP1,
creating a DISC1/DISC1FP1 fusion transcript.6–11
Several small independent studies have reported evidence for
association of single DISC1 single-nucleotide polymorphisms
(SNPs) (coding and non-coding) or haplotypes with SZ, BD, rMDD
and other neuropsychiatric traits, including autism spectrum
disorder, cognition, normative cognitive ageing, anxiety and
structural and functional brain imaging phenotypes.9,12,13 Rare
amino-acid substitution variants in DISC1 have been reported in
cases of SZ,10,11 BD,14 rMDD,13 autism spectrum disorder15 and
agenesis of the corpus callosum,16 as has an increased burden
of rare missense variants in exon 11 of DISC1 for schizoaffective
disorder,17 and for DISC1 pathway genes in SZ.10 In contrast,
a meta-analysis of all known common variants within the DISC
locus, from a total of 11 626 cases and 15 237 controls that
involved the testing of 1241 SNPs, found no evidence that
common variants at the DISC locus are signiﬁcantly associated
with SZ.18 Moreover, the DISC1 locus has not reached genome-
wide signiﬁcance in large-scale meta-analyses of linkage studies of
SZ,19 nor have its common variants in large-scale genome-wide
association studies of SZ, BD or rMDD.20–22 A recent exon-based
study that sequenced 2.7 kb of DISC1 in 727 cases of SZ and 733
controls found 32 rare alleles (minor allele frequency (MAF)o0.01)
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in SZ cases and 40 in European controls with no evidence for a
signiﬁcantly increased burden of likely pathogenic variants.23
DISC1, however, continues to feature strongly in attempts to
assess genome-wide association results in terms of networks24 or
in combination with known biological function.25–27
The biological functions of DISC1 ﬁt well with current
aetiological concepts in SZ-related major mental illness
and cognition.28 DISC1 is a scaffold protein that interacts with,
and modulates the activity of, multiple proteins with key roles in
neurodevelopment, neurogenesis, neuronal migration, integration
and signalling29–31 including the antidepressant and antipsychotic
targets GSK3b32 and PDE4.33 Several common and rare amino-acid
polymorphisms of DISC1 have predicted deleterious effects
on protein function and demonstrable biological effects
in experimental settings.31 The 704C allele is associated with
reduced activity of ERK1 and Akt kinases, altered binding afﬁnities
of DISC1 for NDE1 and NDEL1 and variation in DISC1 oligomeric
status.34–37 The 607F allele results in (a) reduced binding and
centrosomal localisation of PCM1, (b) reduced noradrenaline
neurotransmitter release in SH-SY5Y cells,38 (c) altered
mitochondrial trafﬁcking39 and (d) a partial shift from neuronal
to glial expression in the brain.40 Furthermore, Singh et al.41
reported that 607F impacts negatively on neural progenitor
proliferation in E16 mouse brain, correlates with aberrant wnt
signalling in human lymphoblasts, and is associated with a
neurodevelopmental phenotype in morpholino mutant zebraﬁsh.
R37W lies within an arginine-rich nuclear localisation motif
and a partially overlapping interaction domain for PDE442
and GSK3b.41,43 The 37W allele shows reduced nuclear
DISC1 expression and altered DISC1 regulation of ATF4, a critical
modulator of cAMP signalling and mediator of the stress
response.44
In summary, whereas the primary genetic evidence from the
original Scottish t(1;11) family was signiﬁcant at the genome-wide
signiﬁcance level for both SZ and rMDD and the experimental
evidence and biological plausibility of DISC1 remains strong, the
evidence from subsequent linkage and candidate gene associa-
tion studies is however inconsistent and not supported by
genome-wide association studies or meta-analysis.12 To explore
these contrasting ﬁndings, we aimed here to establish the nature
and frequency of DISC1 genomic sequence variants, identify
rare variants in putative functional domains, and test for effects
of these on cognitive traits and the risk of psychiatric illness.
We comprehensively sequenced 528 kb covering the entire DISC1
locus, including TRAX (also known as TSNAX) for which there is
evidence for intergenic splicing with DISC145 and the intergenic
region, which contains regulatory elements immediately 5’ of
DISC1.13,46–48
MATERIALS AND METHODS
A full summary of the methods can be found in Supplementary
Information. Brieﬂy, all study participants gave signed consent for their
data and samples to be used in studies that have been approved by the
appropriate Research Ethics Committee or the GS access Committee.
Genomic DNA from each individual was whole genome ampliﬁed
in triplicate, the products pooled and ampliﬁed with primer pairs tiled
across 528 kb of TRAX/DISC1 (hg18 chr1:229723339-230251606; hg19
chr1:231656716-232184983). For each sample, the pooled products were
sheared, converted into paired-end Illumina libraries and sequenced on an
Illumina GAII or HiSeq 2000 sequencer to 480% coverage and 430-fold
depth. Sequences were aligned to the UCSC hg18 reference sequence,
variants called using MAQ software49 and the variants in repeats removed.
Ten percent of all remaining variants were validated using Sanger
sequencing chemistry on an ABI3730 sequencer, and the derived
information used to optimise the quality control ﬁlters. After quality
control screening, all exonic and low frequency (MAFo1%) variants were
also validated by Sanger chemistry sequencing as above. The variants were
functionally annotated using SNPnexus50 (http://www.snp-nexus.org).
Non-coding variants were annotated using the UCSC table browser for
the following tracks: ‘RepeatMasker’,51 ‘CpG island’, ‘TFBS conserved’, ‘7x
Reg Potential’ (which substantially overlaps with DNAse hypersensitivity
sites) and/or ‘28-Way Most conserved—PlacMammal’ (http://genome.ucsc
.edu/). Sequence variants classiﬁed as coding were mapped to the DISC1 L
isoform and potential pathogenicity ascribed using Pmut,52 Panther53 and
PolyPhen-2.54 The coding sequence variants were mapped onto
a list of known curated DISC1-interactor binding sites31 and with other
functional elements (for example, phosphorylation sites55). Case–control
association was tested on the combined case samples as well as
individually for SZ, BP and rMDD using Fisher’s exact test. Permutation
was used to derive region-wide P-values and signiﬁcance thresholds.
Quantitative trait association analyses using LBC1936 samples were
performed by linear regression of the trait residuals (adjusted for age
and sex) on the number of minor alleles at each SNP, with empirical
P-values estimated by permutation to avoid issues with the test statistic
distribution caused by the combination of rare variants and slight
deviations from normality in the phenotypes. All association analyses
were performed using PLINK.56 Mark-recapture analysis followed the
Lincoln-Petersen and Modiﬁed Petersen methods57,58 with 95% conﬁdence
intervals calculated following Chapman.59 Burden analysis was performed
in PLINK/SEQ to implement BURDEN and VTTEST with empirical P-values
estimated using permutation. Genotyping of the replication and familial
samples was performed by the Edinburgh Wellcome Trust Clinical
Research Facility Genetics Core using TaqMan SNP genotyping assay
C__33950433_10 with concurrent genotyping of known heterozygotes.
Data access
The accession numbers for sequence data are NCBI ss472328925—
ss472331023.
RESULTS
Sequence analysis
We sequenced 1542 Caucasians from Scotland comprising
240 cases of SZ, 221 cases of BD, 192 cases of rMDD and, as
controls, 889 members of the Lothian Birth Cohort 1936
(LBC1936), which have been extensively phenotyped.60 Each
sample was sequenced to 480% coverage at a minimum of 30-
fold read depth by long-range PCR and sequencing on either
Illumina GAII or HiSeq 2000 sequencers. To ensure a robust
data set, all variants within repetitive regions were removed.
Final quality score thresholds for the data were derived from
capillary sequence validation of 10% of the remaining variants. All
variants with an MAF o1% were validated by ABI3730
sequencing. After quality control, there was no evidence for
sequencing bias between cases and controls (Supplementary
Figure S1). Allele frequencies from our sample showed strong
concordance to those from the European subset of the 1000
Genomes Project61 (Supplementary Figure S2). We report 2718
SNPs in the 1542 samples analysed, 708 at X1% and 2010 at
o1% MAF (Supplementary Table S1). Only 1027 of the 2718 SNPs
(38%) were previously reported in the European subset of the
1000 Genomes Project.61
As deﬁned and annotated by the UCSC genome browser (http://
genome.ucsc.edu), 489 SNPs mapped to regions of regulatory
potential, 177 to non-coding exons (including DISC2) and 36 to
coding regions of exons. Of these 36 variants, 12 were
synonymous changes, 23 were non-synonymous changes, with
one producing a stop codon consistent with the DISC1 Es isoform
(Figure 1; Supplementary Figure S3; Supplementary Tables S1 and
S2). Supplementary Table S3 summarises the overlap between
variants identiﬁed in this study and other DISC1 sequencing
studies and relevant association studies.10,11,13,14,16,17,23,46
Association and segregation of common variants with psychiatric
illness and related quantitative traits
Genome-wide association studies of SZ, BP and rMDD are most
consistent with a polygenic liability for common variants, but they
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also imply that there is real ‘missing’ genetic variation, which is
most likely due to risk variants having low frequency in the
population. To test for evidence of DISC1 association, we applied
the Fisher’s exact test across all variants and all diagnoses
(Figure 2). There was no evidence for SNP association at genome-
wide levels of signiﬁcance for any diagnosis when considered
separately or combined, nor was there evidence for locus-wide
association of variants with SZ or BP. We did detect a novel,
locus-wide empirical association P¼ 0.026 (OR¼ 3.48, 95% CI¼
1.95–6.23, unadjusted P¼ 6.3 10 5) between intronic variant
rs16856199 and rMDD. We speculated that individual risk alleles
might be predicted to segregate with disease in families. Twelve
additional family members were available for genotyping for four
rs16856199 carriers. The rs16856199 risk allele segregated with
rMDD in all four families (Supplementary Figure S4).
We next tested for association of rs1685199 with depression in
three additional sample sets: a group of individuals referred from
primary care to a hospital outpatient clinic (n¼ 467 rMDD
patients), and two population-based samples drawn from primary
care as part of the Generation Scotland: Scottish Family Health
Study consisting of 645 cases with rMDD and 690 cases with single
episode MDD. All three groups were compared with 4017 controls
drawn exclusively from Generation Scotland: Scottish Family
Health Study (Supplementary additional text and Table S4). No
signiﬁcant association was seen with any individual replication set
or all three combined (best P¼ 0.088). Analysis of all three rMDD
sets, both the original set and the two rMDD replication sets, was
supportive of association (1112 rMDD, 4017 controls; P¼ 0.0058,
OR¼ 1.46, 95%CI¼ 1.12–1.91). Combined analysis of both sets of
individuals referred from primary care showed stronger nominal
association (P¼ 0.00065, OR¼ 1.76, 95%CI¼ 1.27–2.44). No asso-
ciation was seen in the combined analysis of both the rMDD and
MDD population-based replication sets (P¼ 0.41). The risk allele
for rs16856199 did not segregate with rMDD in 10 families of
carriers identiﬁed from the Generation Scotland replication
sample (Supplementary Figure S5). This suggests that there is
increased evidence for association of rs16856199 in the more
severely affected individuals.
SNP rs16856199 is on the Affymetrix 6.0 array, but the best
tagging SNP on the Illumina 660W-Quad, Human Hap, Human1M-
Duo arrays is rs16856189. SNP rs16856189 has an r2 of 0.27
with rs16856199, which may explain in part why this association
has not been reported previously in genome-wide association
studies.22,62,63 SNP rs6678723, which lies 2.1 kb distal to this SNP
within intron 11, showed the most signiﬁcant association of DISC1
in the recent mega-analysis of depression (P¼ 0.0092).20
The LBC1936 has quantitative measures of symptoms of
anxiety, depression and the personality trait of neuroticism, plus
psychometrically tested measures of cognitive ability (ﬂuid
(age sensitive) and crystallised (non-age sensitive)) and cognitive
ageing,60,64 which have been shown to be highly heritable and
polygenic.65,66 Association of these traits with DISC1 was tested by
linear regression analyses, co-varied for age at testing and sex
(Supplementary Figures S6–S8). There were no region-wide
signiﬁcant ﬁndings for any of these quantitative traits.
Estimating the net pool of DISC1 variants
To estimate the effective pool of common and rare sequence
variants in the European population, we applied a ‘mark-recapture’
approach (see Supplementary methods) to our data and
that of the 1000 Genomes Project (v3.20101123)67 after
appropriate checks on read depth and Sanger sequence
validation (Supplementary Table S5; Supplementary Figure 9).
Figure 1. TRAX/DISC1 (Disrupted in schizophrenia 1) genomic and exon structure: alignment of coding and regulatory variants. (a) Three-period
moving average of all single-nucleotide polymorphisms (SNPs) identified per 5 kb across the region in this study with TRAX/DISC1 intron/
exons structure given to scale. Total SNP number (black), those with a minor allele frequency (MAF) of o1% SNPs (blue), those X1% MAF
(green), rs16856199 (arrow). For comparison, the number of SNPs identified in the 1000 genomes (red, dashed) and the number of bases
repeat masked (top black) and 7x regulatory potential (top blue) are also shown. Exon and intron structure of TRAX and DISC1 are drawn to
scale. (b) The position and diagnoses of exonic or regulatory SNPs. SNPs not seen previously (underlined), synonymous SNPs (black) and
non-synonymous SNPs (red), stop or putative splice SNPs (green). Novel SNPs not previously reported in the European samples of the
1000 Genomes Project (v3.20101123) or the NHLBI GO Exome Sequencing Project (ESP6500) or relevant sequencing and association
studies10,16,17,64,65 are underlined.
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The total number of DISC1 SNPs X1% MAF was estimated at 905
(95%CI¼ 905±5), of which 901 (99.5%) are known (Supple-
mentary Table S6). The number of rare variants (o1% MAF) is less
conﬁdently predicted, but is likely to be substantially higher
(95%CI¼ 3777±252) (Supplementary Table S6). Thus, despite the
B2500 European genomes in which the DISC1 locus has been
completely sequenced and the 2305 rare DISC1 variants now
known, B40% or more remain to be discovered, and will be
essentially ‘private’.
Rare amino-acid substitutions
Of the 17 rare coding SNPs previously reported for
DISC1,10,16,17,68,69 we identiﬁed 12 (70.6%) plus an additional
8 non-synonymous variants, of which 5 are also absent from
the European samples of both the 1000 Genomes Project
(v3.20101123)61 and the Exome Variant Server (NHLBI GO Exome
Sequencing Project (ESP), Seattle, WA; http://evs.gs.washington.
edu/EVS/; September, 2012), and previous DISC1 sequencing
studies.10,11,13,14,16,17,23,46,70 (Figure 1; Supplementary Figure S3;
Supplementary Tables S2 and S3).
Five variants, R37W, T453M, T603M, L607F and S704C, are
predicted to be deleterious by all three applied prediction
algorithms (PolyPhen-2, Pmut and Panther; Supplementary
Table S2). From this set, the functional effects of the common
variants L607F (rs6675281) and S704C (rs821616) have been well
documented in the literature, as mentioned earlier. R37W lies
within a deﬁned nuclear localisation signal71 and PDE4B binding
site72 and is seen in a single case of rMDD (discussed at the end of
this section). T453M is present at low frequency in cases and
control individuals, both in this study and others (Supplementary
Table S3). T603M was only identiﬁed in a single control, but
Song et al.11 reported a T603I variant in a schizophrenic individual
that was absent in their set of control individuals (Supplementary
Table S3).
Five variants were only observed in affected individuals from
our study (R37W, A83V, W160L, R233K and R418H), but not in 889
control individuals. Four of these non-synonymous case-only
singletons are located in the largest coding exon, DISC1 exon 2,
and the remaining variant is in DISC1 exon 4 (Figure 1). A83V was
seen in a single individual with BD; this variant is predicted to be
deleterious by PolyPhen-2 and Pmut and has been shown to affect
wnt signalling.41 It was however observed at low frequency in
controls and in individuals with partial agenesis of the corpus
callosum in previous studies (Supplementary Table S3).11,14,16
Apart from R37W and A83V, none of the three remaining non-
synonymous variants, W160L, R233K and R418H, are consistently
predicted by the three prediction algorithms to have functional
effects (Supplementary Table S2). 160L and 418H were detected in
single SCZ individuals and have also previously been reported
in individuals with SCZ; but 160L has also been detected in
control individuals.10 The variant 233K has not been previously
reported, and was identiﬁed in an individual with rMDD. No non-
synonymous variants in TRAX were found in cases only. A single
Figure 2. Region-wide association analysis for schizophrenia, bipolar and recurrent major depressive disorder. Nominal P-values for Fisher’s
exact tests are plotted against genomic location (hg18) across the TRAX/DISC1 (Disrupted in schizophrenia 1) locus. Reference lines represent 1%
(dashed) and 5% (solid) region-wide empirical thresholds. Only the association of rs16856199 and recurrent major depressive disorder remains
significant at the 5% threshold (arrow).
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stop mutation was identiﬁed in a control individual and produces
an alternative stop site for the DISC1 Es isoform. These variants
can now be tested for potential impact on DISC1 biophysical
properties, protein interaction and biological function.29–31
Evidence for familial segregation was sought for ﬁve rare exonic
variants where additional family members were available, but
none segregated perfectly or unequivocally with diagnosis
(Supplementary Figure 9). Of note however was the identiﬁcation
of the non-synonymous amino-acid variant R37W (rs137948488),
ﬁrst reported68 in a subject with SZ, and seen here in a single case
of rMDD. R37 is strictly conserved among orthologues and recent
publications, including our own, have demonstrated biological
effects of 37W on DISC1 interactions,32,73 and shown a dominant-
negative effect on the sub-cellular distribution of DISC1.44 Five
additional family members of the 37W carrier were available for
genotyping diagnosed with rMMD, generalised anxiety disorder,
bipolar II or no psychiatric diagnosis at the time of assessment.
The R37W mutation was present in relatives with rMDD and
generalised anxiety disorder, but not in a relative with bipolar II, or
any unaffected individual (Figure 3).
Burden analysis for putative functional variants
To explore the burden of SNPs of potential functional signiﬁcance,
all variants with MAF o1% were ﬁrst validated by ABI3730
sequencing. There was no signiﬁcant overall difference in the
number of singleton variants (Supplementary Figure S10) or in the
overall number of minor alleles by diagnosis (see Supplementary
Methods). SNPs were classiﬁed on the basis of bioinformatic
annotation into seven functional classes: those in exons including
untranslated exons, coding sequence, non-synonymous coding
SNPs, conserved regions, regions with regulatory potential,
conserved transcription factor binding sites and CpG islands
(see Materials and methods and Supplementary Table S7).
The empirical P-values for the burden analysis were obtained by
permutation correcting for the multiple thresholds tested, but not
for the multiple functional subgroups or diagnostic classes
(SZ, BP and rMDD and all cases combined), therefore all results
are reported as nominal signiﬁcance values (Supplementary Table
S8; Supplementary Methods). Details of nominally signiﬁcant
results are given in Table 1. For rMDD only, there was a nominally
signiﬁcant (P¼ 0.044) excess of minor alleles for SNPs with
regulatory potential across all frequencies, and for rare SNPs in
conserved regions with MAF p0.18% (P¼ 0.022). Nominally
signiﬁcant association was found in the LBC1936 data between
the burden of minor alleles across all frequencies for SNPs in
conserved transcription factor binding sites and increased
symptoms of depression, a measure of depressed mood at the
time of testing (Table 1). In addition, a nominally signiﬁcant
increase in burden of minor alleles for SNPs in CpG islands or
coding SNPs was observed with Moray House Test scores,
measures of cognitive ability (Supplementary Table S9). Summa-
ries of the nominally signiﬁcant results are given in Table 1.
DISCUSSION
Diagnoses of SZ, BP and rMDD were all present in the original
Scottish family carrying the translocation that disrupts DISC1. All
three DSMIV diagnoses have a strong and overlapping genetic
component, but robust statistical analysis of gene-level contribu-
tions to risk are complicated by extensive genetic heterogeneity
within and between diagnoses.4 We have provided the most
comprehensive landscape of genetic variation at the DISC1 locus
to date in patients with this spectrum of psychiatric illness and in
healthy population controls with quantitative measures of mood
and cognition. Comparison between our sequencing study and
that of the 1000 Genomes Project conﬁrms that current genome-
wide association studies effectively captures the majority of
common (but not rare) variants in the European population. Our
sample size is large by current sequencing study standards, but
we lack power to detect genome-wide signiﬁcant P-values for
either common or rare variants (see Supplementary Information
and Supplementary Figure S11 for further details and also Kiezun
et al.).74 Indeed, the predicted abundance of independent rare
variants at this (and any other given) locus makes it highly
improbable that any one will contribute to illness in the population
at a frequency that will be statistically signiﬁcant, given the numbers
of patients we can afford to analyse by direct sequencing.74
We observed no evidence for association at the whole-genome
level of statistical signiﬁcance between individual rare or
common variants and either psychiatric illness or cognition. This
is consistent with recent ﬁndings,74 which suggest that much
larger samples would be required to detect such associations.
Burden analysis of multiple rare and/or deleterious putative
functional variants also failed to show association with these traits.
We do report both functional and putative regulatory variants that
are both individually, and by functional classiﬁcation, nominally
associated with rMDD and/or cognitive ability at the locus-wide
level of signiﬁcance.
Our study identiﬁed a novel association between intronic SNP
rs16856199 and rMDD in hospital-referral subjects. Segregation
with diagnosis in the relatives of these probands corroborated the
association, but further studies are required to understand the lack
of replication in population-based cohorts with depression. This
may be due to inherent differences between patients recruited
from hospital-referral compared with those from population-
based cohorts. Cohorts from primary care are more likely to have a
family history of depression,75 and may have more physical and
psychiatric comorbidity in general. Conversely, the population-
based sample may have shorter, less severe episodes76 than the
hospital-based cohorts.77 However, given the modestly signiﬁcant
P-value for rMDD in the discovery cohort, the number
of psychiatric traits examined and the lack of replication, it is
possible that the observed association is due to chance.
The nominal associations of the burden of common (threshold
MAF¼ 30.7%) and rare potentially regulatory variants (threshold
MAF¼ 0.060%) to measures of cognitive ability merit further
study. A yet-to-be-deﬁned subset of these is likely to have critical
roles is spatial and temporal regulation of transcription and
splicing.46,78 This highlights the need for annotation tools with
improved predictive value for non-coding variants.79
More importantly, our study demonstrates that substantial
coding and non-coding genetic variation at the DISC1 locus
Figure 3. Segregation of the R37W polymorphism with psychiatric
diagnoses in a small Scottish family. The proband of the family is
indicated (arrow). The codon containing the T allele encodes for the
amino acid tryptophan (W) and the codon containing the A allele
encodes arginine (R). rMDD, recurrent major depressive disorder;
BP2, bipolar II.
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remains undiscovered. Despite sequencing over 1500 subjects,
we have probably captured only B40% of the extant DISC1
variants in just the European population. Crowley et al.23
sequenced 2.7 kb of DISC1 exons and 5’ and 3’ regulatory
sequence in 1460 samples of European or African origin.
We observed 13/38 (34%) of the variants genotyped in the
replication phase, supporting the argument for an abundance
of rare variants.
The level of sequence variation identiﬁed in our study is
unlikely to be exceptional, and indeed is consistent with evidence
emerging from other genome sequencing studies.74
Consequently, it will be challenging to demonstrate robust
(replicated) association by statistical evidence alone in case–
control studies, exceptionally so with the numbers of patients that
are currently affordable for sequencing. The original t(1;11) family
illustrates the added issue of variable penetrance and cross-
boundary diagnosis for a given mutation: B70% of carriers had
SZ, BP or rMDD, but B30% had no formal psychiatric diagnosis,
yet t(1;11) carriers, including both affected and unaffected, had
ERP P300 measures in the range typical of individuals with SZ.5
The original identiﬁcation of 37W in a case of SZ and here in a case
of rMDD (and two offspring, one with rMDD, the other generalised
anxiety disorder) may suggest variable penetrance of this
biologically functional variant.44 Of note, the 37W variant was
not observed in 10 000 control individuals,11 the 1000 Genomes
project,61 the NHLBI GO Exome Sequencing Project (ESP), nor any
of our 889 control samples. These ﬁndings on R37W reinforce the
probable importance of this domain for DISC1 subcellular
distribution and binding of interacting proteins31,44 and add to
the weight of evidence for other functional studies of DISC1
amino-acid substitutions.41 Each observed amino-acid substitution
provides a similar opportunity to tease out the relationships
between genotype and phenotype and between structure and
function.29,31 Overall, these results demonstrate a high level
of sequence variation in DISC1, a subset of which may contribute
to psychiatric disorder in some individuals who will be typically
rare in the population precluding classical statistical analysis and
requiring biological validation. This predicts a population-speciﬁc
contribution of rare casual variants to risk.80 Our results indicate
the potential value of sequencing non-coding regions of the
genome, which may harbour disease-associated regulatory
variants. Our ﬁndings of both functional and putative regulatory
variants nominally associated with depression and cognitive
ability merit replication in independent samples and biological
exploration.
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Table 1. Summary of nominally significant burden results
Case–control Trait SNP
subset
Test Average excess of
variants in cases
Optimised MAF
threshold (N. SNP)
P-value
rMDD RegPot BURDEN 1.39 — 0.044
rMDD PhastCon VTTEST 1.20 0.0018 (31) 0.022
Quantitative
traits
Trait SNP
subset
Test Effect size (beta) Optimised MAF
threshold (N. SNP)
P-value
Symptoms of depressiona TFBS BURDEN 0.062 — 0.032
Moray House Test at age 70b PhastCon VTTEST  0.074 0.0013 (21) 0.030
Moray House Test at age 70 adjusted for the
Moray House Test score at age 11b
CpG VTTEST  0.064 0.00060 (2) 0.047
Moray House Test at age 11b Coding VTTEST  0.101 0.00070 (12) 0.028
Moray House Test at age 11b CpG VTTEST  0.097 0.31(3) 0.040
Abbreviations: MAF, minor allele frequency; rMDD, recurrent major depressive disorder; SNPs, single-nucleotide polymorphisms.
See main text for trait descriptions and Supplementary Table S8 for results on all diagnoses and traits. Quantitative trait analysis was one-tailed under the
hypothesis that an increased burden of minor alleles would reduce scores for cognitive traits and increase scores for anxiety, depression and neuroticism.
References for all quantitative traits are available in the open-access Lothian Birth Cohort protocol paper (Deary et al.60). Coding: SNPs in protein-coding
regions of exons including both synonymous and non-synonymous SNPs. PCon, SNPs within regions of conservation in placental mammals (PhastCon, UCSC).
RegPot: SNPs with putative regulatory potential (UCSC, 7 x regulatory potential). CpG: SNPs in CpG islands commonly associated with promoter regions.
aTested using the Hospital Anxiety Depression Scales. bThe Moray House Test is the general cognitive test—mostly a verbal reasoning, IQ-type test—that was
used in the Scottish Mental Survey 1947.
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